Yuhong Fu

Dr. Yuhong Fu

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2024 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
NJNanna Møller Jensen
Nanna Møller Jensen
YFYuhong Fu
Yuhong Fu
CBCristine Betzer
Cristine Betzer
HLHongyun Li
Hongyun Li
SESara Elfarrash
Sara Elfarrash
PJPoul Henning Jensen
Poul Henning Jensen
α-Synuclein proximity ligation assay (PLA) has proved a sensitive technique for detection of non-Lewy body α-synuclein aggregate pathology. Here, we describe the MJF-14 PLA, a new PLA towards aggregated α-synuclein with unprecedented specificity, using the aggregate-selective α-synuclein antibody MJFR-14-6-4-2 (hereafter MJF-14). Signal in the assay correlates with α-synuclein aggregation in cell culture and human neurons, induced by α-synuclein overexpression or pre-formed fibrils. Co-labelling of MJF-14 PLA and pS129-α-synuclein immunofluorescence in post-mortem cases of dementia with Lewy bodies shows that while the MJF-14 PLA reveals extensive non-inclusion pathology, it is not sensitive towards pS129-α-synuclein-positive Lewy bodies. In Parkinson’s disease brain, direct comparison of PLA and immunohistochemistry with the MJF-14 antibody shows widespread α-synuclein pathology preceding the formation of conventional Lewy pathology. In conclusion, we introduce an improved α-synuclein aggregate PLA to uncover abundant non-inclusion pathology, which deserves future validation with brain bank resources and in different synucleinopathies.

20 April 2023 in Micron
Verified
Journal Article
Closed access
QLQin Liu
Qin Liu
YFYuhong Fu
Yuhong Fu
ZQZonghua Qin
Zonghua Qin
Yun WangYun Wang
Yun Wang
SZShanshan Zhang
Shanshan Zhang
MRMeimei Ran
Meimei Ran

5 June 2024 in Genes
Verified
Journal Article
Open access
PDF file
GAGabrielle L. Adler
Gabrielle L. Adler
KLKelvin Le
Kelvin Le
YFYuhong Fu
Yuhong Fu
WKWoojin Kim
Woojin Kim
Human endogenous retroviruses (HERVs) are DNA transposable elements that have integrated into the human genome via an ancestral germline infection. The potential importance of HERVs is underscored by the fact that they comprise approximately 8% of the human genome. HERVs have been implicated in the pathogenesis of neurodegenerative diseases, a group of CNS diseases characterized by a progressive loss of structure and function of neurons, resulting in cell death and multiple physiological dysfunctions. Much evidence indicates that HERVs are initiators or drivers of neurodegenerative processes in multiple sclerosis and amyotrophic lateral sclerosis, and clinical trials have been designed to target HERVs. In recent years, the role of HERVs has been explored in other major neurodegenerative diseases, including frontotemporal dementia, Alzheimer’s disease and Parkinson’s disease, with some interesting discoveries. This review summarizes and evaluates the past and current research on HERVs in neurodegenerative diseases. It discusses the potential role of HERVs in disease manifestation and neurodegeneration. It critically reviews antiretroviral strategies used in the therapeutic intervention of neurodegenerative diseases.

12 May 2025 in Nature Reviews Neurology
Verified
Journal Article
Closed access
PDF file
YFYuhong Fu
Yuhong Fu
GHGlenda M. Halliday
Glenda M. Halliday

30 April 2018 in Experimental Neurobiology
Verified
Journal Article
Open access
PDF file
ZRZoltán Rusznák
Zoltán Rusznák
GSGulgun Sengul
Gulgun Sengul
GPGeorge Paxinos
George Paxinos
WKWoojin Scott Kim
Woojin Scott Kim
YFYuhong Fu
Yuhong Fu
Zoltán Rusznák, Gulgun Sengul, George Paxinos, Woojin Scott Kim and YuHong Fu. Exp Neurobiol 2018;27:94-102. https://doi.org/10.5607/en.2018.27.2.94

25 February 2023 in Cells
Verified
Journal Article
Open access
PDF file
JHJen-Hsiang Tony Hsiao
Jen-Hsiang Tony Hsiao
OTOnur Tanglay
Onur Tanglay
ALAnne Ailina Li
Anne Ailina Li
ASAysha Strobbe
Aysha Strobbe
WKWoojin Kim
Woojin Kim
YFYuhong Fu
Yuhong Fu
Multiple system atrophy (MSA) is a debilitating movement disorder with unknown etiology. Patients present characteristic parkinsonism and/or cerebellar dysfunction in the clinical phase, resulting from progressive deterioration in the nigrostriatal and olivopontocerebellar regions. MSA patients have a prodromal phase subsequent to the insidious onset of neuropathology. Therefore, understanding the early pathological events is important in determining the pathogenesis, which will assist with developing disease-modifying therapy. Although the definite diagnosis of MSA relies on the positive post-mortem finding of oligodendroglial inclusions composed of α-synuclein, only recently has MSA been verified as an oligodendrogliopathy with secondary neuronal degeneration. We review up-to-date knowledge of human oligodendrocyte lineage cells and their association with α-synuclein, and discuss the postulated mechanisms of how oligodendrogliopathy develops, oligodendrocyte progenitor cells as the potential origins of the toxic seeds of α-synuclein, and the possible networks through which oligodendrogliopathy induces neuronal loss. Our insights will shed new light on the research directions for future MSA studies.